The uncoupling protein 2 -866g > a polymorphism is associated with the risk of ischemic stroke in chinese type 2 diabetic patients

CNS Neuroscience and Therapeutics

Volumn 18, Issue 8, 2012, Pages 636-640

  Chai, Yi ^a,b   Gu, Bing ^b   Qiu, Jin Rong ^b   Yi, Hong Gang ^b   Zhu, Qian ^b   Zhang, Lu ^b   Hu, Gang ^a  

^a NANJING UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

866G>A SNP; Stroke; Type 2 diabetes; Uncoupling protein 2 promoter

Indexed keywords

ADENINE; GUANINE; UNCOUPLING PROTEIN 2;

ADULT; AGED; ALLELE; ARTICLE; BRAIN ISCHEMIA; CASE CONTROL STUDY; CHINESE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RISK; RISK FACTOR; STRATIFIED SAMPLE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN ISCHEMIA; CHINA; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DNA; FEMALE; GENOTYPE; HUMANS; ION CHANNELS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; ODDS RATIO; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK; SEX FACTORS; STROKE;

EID: 84864758876     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2012.00333.x     Document Type: Article

References (37)

1. World Health Organization. World Health Statistics 2008.
2. Arsenijevic D, Onuma H, Pecqueur C, et al. Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production. Nat Genet 2000;26:435-439.
3. Blanc J, Alves-Guerra MC, Esposito B, et al. Protective role of uncoupling protein 2 in atherosclerosis. Circulation 2003;107:388-390.
4. Lee KU, Lee IK, Han J, et al. Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis. Circ Res 2005;96:1200-1207.
5. Nègre-Salvayre A, Hirtz C, Carrera G, et al. A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation. FASEB J 1997;11:809-815.
6. Park JY, Park KG, Kim HJ, et al. The effects of the overexpression of recombinant uncoupling protein 2 on proliferation, migration and plasminogen activator inhibitor 1 expression in human vascular smooth muscle cells. Diabetologia 2005;48:1022-1028.
7. McLeod CJ, Aziz A, Hoyt RF Jr, et al. Uncoupling proteins 2 and 3 function in concert to augment tolerance to cardiac ischemia. J Biol Chem 2005;280:33470-33476.
8. Esterbauer H, Schneitler C, Oberkofler H, et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 2001;28:178-183.
9. Krempler F, Esterbauer H, Weitgasser R, et al. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 2002;51:3331-3335.
10. Sesti G, Cardellini M, Marini MA, et al. A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects. Diabetes 2003;52:1280-1283.
11. Wang H, Chu WS, Lu T, et al. Uncoupling protein-2 polymorphisms in type 2 diabetes, obesity, and insulin secretion. Am J Physiol Endocrinol Metabol 2004;286:e1-e7.
12. Reis AF, Dubois-Laforgue D, Bellanné-Chantelot C, Timsit J, Velho G. A polymorphism in the promoter of UCP2 gene modulates lipid levels in patients with type 2 diabetes. Mol Genet Metabol 2004;82:339-344.
13. Nedergaard M. Transient focal ischemia in hyperglycemic ats is associated with increased cerebral infarction. Brain Res 1987;408:79-85.
14. Siesjo BK, Katsura K, Kristian T. Acidosis-related damage. Adv Neurol 1996;71:209-233.
15. Li PA, Siesjo BK. Role of hyperglycaemia-related acidosis in ischaemic brain damage. Acta Physiol Scand 1997;161:567-580.
16. Li PA, Gisselsson L, Keuker J, et al. Hyperglycemia-exaggerated ischemic brain damage following 30 mins of middle cerebral artery occlusion is not due to capillary obstruction. Brain Res 1998;804:36-44.
17. Gisselsson L, Smith ML, Siesjo BK. Hyperglycemia and focal brain ischemia. J Cereb Blood Flow Metabol 1999;19:288-297.
18. Gaitonde MK, Jones J, Evans G. Metabolism of glucose into glutamate via the hexose monophosphate shunt and its inhibition by 6-aminonicotinamide in rat brain in vivo. Proc R Soc Lond B Biol Sci 1987;231:71-90.
19. Li PA, Shuaib A, Miyashita H, He QP, Siesjö BK, Warner DS. Hyperglycemia enhances extracellular glutamate accumulation in rats subjected to forebrain ischemia. Stroke 2000;31:183-192.
20. Nelson CW, Wei EP, Povlishock JT, et al. Oxygen radicals in cerebral ischemia. Am J Physiol 1992;263:H1356-1362.
21. Nicholls DG, Ward MW. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: Mortality and millivolts. Trends Neurosci 2000;23:166-174.
22. Muranyi M, Ding C, He Q, Lin Y, Li PA. Streptozotocin-induced diabetes causes astrocyte death after ischemia and reperfusion injury. Diabetes 2006;55:349-355.
23. Russell JW, Golovoy D, Vincent AM, et al. High glucoseinduced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 2002;16:1738-1748.
24. Mastrocola R, Restivo F, Vercellinatto I, et al. Oxidative and nitrosative stress in brain mitochondria of diabetic rats. J Endocrinol 2005;187:37-44.
25. Klingenberg M, Echtay KS. Uncoupling proteins: The issues from a biochemist point of view. Biochim Biophys Acta 2001;1504:128-143.
26. Richard D, Clavel S, Huang Q, Sanchis D, Ricquier D. Uncoupling protein 2 in the brain: Distribution and function. Biochem Soc Trans 2001;29:812-817.
27. Mattiasson G, Sullivan PG. The emerging functions of UCP2 in health, disease, and therapeutics. Antioxid Redox Signal 2006;8:1-38.
28. Zhang CY, Baffy G, Perret P, et al. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 2001;105:745-755.
29. Joseph JW, Koshkin V, Zhang CY, et al. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 2002;51:3211-3219.
30. Krauss S, Zhang CY, Scorrano L, et al. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. J Clin Invest 2003;112:1831-1842.
31. Mattiasson G, Shamloo M, Gido G, et al. Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma. Nat Med 2003;9:1062-1068.
32. Parton LE, Ye CP, Coppari R, et al. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 2007;449:228-232.
33. Esterbauer H, Schneitler C, Oberkofler H, et al. A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet 2001;28:178-183.
34. Krempler F, Esterbauer H, Weitgasser R, et al. A functional polymorphism in the promoter of UCP2 enhances obesity risk but reduces type 2 diabetes risk in obese middle-aged humans. Diabetes 2002;51:3331-3335.
35. Dhamrait SS, Stephens JW, Cooper JA, et al. Cardiovascular risk in healthy men and markers of oxidative stress in diabetic men are associated with common variation in the gene for uncoupling protein 2. Eur Heart J 2004;25:468-475.
36. Yamasaki H, Sasaki H, Ogawa K, et al. Uncoupling protein 2 promoter polymorphism -866G/A affects peripheral nerve dysfunction in Japanese type 2 diabetic patients. Diabetes Care 2006;29:888-894.
37. Oberkofler H, Iglseder B, Klein K, et al. Associations of the UCP2 gene locus with asymptomatic carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2005;25:604-610.